Concepedia

Publication | Open Access

Combating acquired resistance to MAPK inhibitors in melanoma by targeting Abl1/2-mediated reactivation of MEK/ERK/MYC signaling

42

Citations

60

References

2020

Year

References

YearCitations

Page 1